Cardiogenic Shock

This page includes content on technologies to treat cardiogenic shock, including percutaneous ventricular assist devices (pVAD), intra-aortic balloon pumps (IABP) and extracorporeal membrane oxygenation (ECMO). This condition occurs when the heart can no longer pump enough oxygenated blood to the body. The most common cause of cardiogenic shock is damage to the heart from a severe heart attack. The standard of care for this condition for more than 20 years has a 50 percent survival rate, but improvements have recently been seen in studies using early pVAD intervention prior to percutaneous coronary intervention (PCI). For more information, visit the National Institute of Health (NIH) cardiogenic shock information page

Videos | Hemodynamic Support Devices

There was a 77 percent increase in survival in cardiogenic shock patients treated using a new protocol in the National ...

Home September 22, 2019
Home
Videos | Hemodynamic Support Devices

A discussion with William O'Neill, M.D., director of the structural heart program, Henry Ford Hospital, and Michele ...

Home September 12, 2019
Home
News | Cardiogenic Shock

May 20, 2019 – A newly released expert consensus statement proposes a classification schema for cardiogenic shock (CS) t ...

Home May 20, 2019
Home
Technology | Ventricular Assist Devices (VAD)

May 14, 2019 — The U.S. Food and Drug Administration (FDA) has approved the expansion of Abiomed’s Impella 5.0 and ...

Home May 14, 2019
Home
Podcast | Hemodynamic Support Devices

This podcast is a discussion with William O'Neill, M.D., director of the structural heart program, Henry Ford Hospital ...

Home May 02, 2019
Home
Blog | Cath Lab

Clinical study data makes the world go around in cardiology and is the basis of setting guidelines in evidence-based ...

Home February 20, 2019
Home
Sponsored Content | Videos | Heart Failure

William O'Neill, M.D., highlights best practice protocols based on Impella Quality database and real-world evidence ...

Home February 13, 2019
Home
The Abiomed Impella RP had higher than expected mortality in its post approval study, much higher than in its pre-market approval study. The vendor and the FDA believe this might be due to poor patient selection and implanting the device too late to aid the patient.
Feature | Hemodynamic Support Devices | Dave Fornell, Editor

The U.S. Food and Drug Administration (FDA) sent a letter to cardiologists this week to explain its evaluation of high ...

Home February 05, 2019
Home
Sponsored Content | Videos | Hemodynamic Support Devices

Michael Amponsah, M.D., FACC, an interventional cardiologist at Mohawk Valley Health System, shares a case of Impella CP ...

Home December 13, 2018
Home
Videos | Hemodynamic Support Devices

Nevin Kapur, M.D., FAHA, FACC, FSCAI, executive director, Cardiovascular Center for Research and Innovation, Tufts ...

Home October 01, 2018
Home
Two versions of the Abiomed Impella percutaneous ventricular assist device being shown at ACC 2018. Impella is the only device currently cleared by the FDA for use in cardiogenic shock.
Feature | Hemodynamic Support Devices | Emmanouil S. Brilakis, M.D., Ph.D., FSCAI and Srihari S. Naidu, M.D., FSCAI
Cardiogenic shock (CS) is a low-cardiac-output state resulting in life-threatening end-organ hypoperfusion and hypoxia ...
Home July 08, 2018
Home
William O'Neill, M.D., unveils the Detroit Cardiogenic Shock Initiative at Henry Ford Hospital. The program uses new protocols to reduce cardiogenic shock mortality by 50 percent by using early hemodyanmic support.
Feature | Hemodynamic Support Devices | Dave Fornell, Editor

About 50 percent of patients in cardiogenic shock do not survive, and account for about 90,000 heart attack patients a ...

Home June 22, 2018
Home
News | Hemodynamic Support Devices

February 15, 2018 — Abiomed Inc. announced that it received an expanded U.S. Food and Drug Administration (FDA) Pre ...

Home February 15, 2018
Home
News | ECMO Systems

December 19, 2017 — A team of researchers at the National Institute for Health Research (NIHR) Leicester Biomedical ...

Home December 19, 2017
Home
Videos | Hemodynamic Support Devices

A discussion with William W. O’Neill, M.D., medical director, Center for Structural Heart Disease, Henry Ford Hospital ...

Home November 09, 2017
Home
Subscribe Now